Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03244631 · ClinicalTrials.gov registry record · NA
Pain Control in Hip Arthroscopy: Comparing Lumbar Plexus Versus Peri-capsular Injection
A NA study of Hip Arthroscopy and Nerve Block, sponsored by Washington Orthopaedics and Sports Medicine.
- Completed
- Registry status
- NA
- Development phase
- 64
- Enrollment target
- 1
- Study location
NCT03244631: Completed NA study of Hip Arthroscopy and Nerve Block, sponsored by Washington Orthopaedics and Sports Medicine.
NCT03244631 is a NA study of Hip Arthroscopy and Nerve Block that has completed, run by Washington Orthopaedics and Sports Medicine. The registered enrollment target is 64 participants, below the 1,121-participant average among 10 other Hip Arthroscopy trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03244631, a NA study of Hip Arthroscopy and Nerve Block, has completed, sponsored by Washington Orthopaedics and Sports Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 64 participants
- Enrollment target
- 1
- Study location
Study Summary
Comparison of lumbar plexus nerve block versus pericapsular injection for pain control during hip arthroscopy
Primary Outcome
Compare post-operative pain scores in the immediate post-operative period as defined by visual-analog pain scale at the time point of one hour spent in the post-anesthesia care unit (PACU).
Conditions Studied
Interventions
- PROCEDURE Lumbar Plexus BLock
- PROCEDURE Pericapsular injection
Study Locations (1)
Maryland
- Washington Orthopedics and Sports Medicine - Chevy Chase
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2017-09-26 |
| Est. Completion | 2020-02-01 |
| Phase | NA |
What the finished NCT03244631 record still lists
NCT03244631 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 64 participants, a relatively small participant target, below the 1,121-participant average among 10 other Hip Arthroscopy trials with a reported enrollment target (94% lower).
The record links to 2 conditions, with Hip Arthroscopy appearing as the primary indexed condition, and to 2 interventions - of which Lumbar Plexus BLock is the first listed.
NCT03244631 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT03244631 about?
NCT03244631 is a clinical study titled "Pain Control in Hip Arthroscopy: Comparing Lumbar Plexus Versus Peri-capsular Injection". Comparison of lumbar plexus nerve block versus pericapsular injection for pain control during hip arthroscopy
What is the current status of trial NCT03244631?
This trial is currently completed. It is a NA study. The enrollment target is 64 participants. The study started on 2017-09-26. Estimated completion is 2020-02-01.
What conditions does trial NCT03244631 study?
This clinical trial studies the following conditions: Hip Arthroscopy, Nerve Block.
What interventions are being tested in trial NCT03244631?
The interventions under investigation include: Lumbar Plexus BLock (PROCEDURE), Pericapsular injection (PROCEDURE).
Who is sponsoring clinical trial NCT03244631?
This trial is sponsored by Washington Orthopaedics and Sports Medicine, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03244631 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hip Arthroscopy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03244631's enrollment target sits among peer trials
64 10th of 10 higher than 1 of 10 other Hip Arthroscopy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hip Arthroscopy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Absorbable vs Non-Absorbable Sutures for Hip Capsular Closure
RECRUITING · NA
-
Arthroscopic Labral Repair Versus Physical Therapy for Tears of the Acetabular Labrum
ACTIVE NOT RECRUITING · NA
-
Effect of Post-operative Brace on Pain and Patient Outcomes Following Hip Arthroscopy for FAIS
ACTIVE NOT RECRUITING · NA
-
CREST: Capsular Repair During Hip Arthroscopy
ACTIVE NOT RECRUITING · NA
-
Lumbar Plexus Block vs Fascia Iliaca Block After Hip Arthroscopy
COMPLETED · NA
-
PENG Block for Arthroscopic Hip Surgery
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01853631 · 64 participants · Phase 1
Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN)
- NCT03739502 · 64 participants · Phase 2
A Randomized Phase II Study of Hyperbaric Oxygen in Improving Engraftment in Umbilical Cord Blood Stem Cell Transplant
- NCT03739814 · 64 participants · Phase 2
Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia
- NCT03866408 · 64 participants · Early Phase 1
Insulin Regulation of Lipolysis and Lipolysis Proteins
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI